63 related articles for article (PubMed ID: 38454413)
1. WTAP-induced N
Liu QZ; Zhang N; Chen JY; Zhou MJ; Zhou DH; Chen Z; Huang ZX; Xie YX; Qiao GL; Tu XH
Cancer Sci; 2024 Jun; 115(6):1749-1762. PubMed ID: 38508217
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Expression of Programmed Death Ligand- 1 (PD-L1) in Colorectal Carcinoma; A Cross-sectional Study.
Tadachina S; Devi Shivalingaiah S; Shetty M
Iran J Pathol; 2024; 19(1):22-30. PubMed ID: 38864082
[TBL] [Abstract][Full Text] [Related]
3. SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion.
Leuzzi G; Vasciaveo A; Taglialatela A; Chen X; Firestone TM; Hickman AR; Mao W; Thakar T; Vaitsiankova A; Huang JW; Cuella-Martin R; Hayward SB; Kesner JS; Ghasemzadeh A; Nambiar TS; Ho P; Rialdi A; Hebrard M; Li Y; Gao J; Gopinath S; Adeleke OA; Venters BJ; Drake CG; Baer R; Izar B; Guccione E; Keogh MC; Guerois R; Sun L; Lu C; Califano A; Ciccia A
Cell; 2024 Feb; 187(4):861-881.e32. PubMed ID: 38301646
[TBL] [Abstract][Full Text] [Related]
4. IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.
Simoni O; Scarpa M; Castagliuolo I; Stepanyan A; Angriman I; Kotsafti A; Nacci C; Scognamiglio F; Negro S; D'Angelo A; Chiminazzo V; Businello G; Ruffolo C; Salmaso R; Franzato B; Gruppo M; Pilati P; Scapinello A; Pozza A; Stecca T; Massani M; Cataldo I; Brignola S; Dei Tos AP; Ceccon C; Guzzardo V; Vignotto C; Facci L; Maretto I; Agostini M; Marchegiani F; Becherucci G; Zizzo M; Bordignon G; Merenda R; Pirozzolo G; Recordare A; Pozza G; Godina M; Mondi I; Verdi D; Lio CD; Laurino L; Saadeh L; Rivella G; Guerriero S; Romiti C; Portale G; Cipollari C; Spolverato YC; Noaro G; Cola R; Candioli S; Gavagna L; Ricagna F; Ortenzi M; Guerrieri M; Tagliente G; Tomassi M; Tedeschi U; Salmaso B; Buzzi G; Parini D; Prando D; Zuin M; Bergamo F; Zagonel V; Porzionato A; Cavallin F; Camillo BD; Cristoforo LD; Bao QR; Pucciarelli S; Bardini R; Spolverato G; Fassan M; Scarpa M;
Cancer; 2024 Jul; 130(13):2272-2286. PubMed ID: 38644692
[TBL] [Abstract][Full Text] [Related]
5. SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells.
Zhai P; Zhang H; Li Q; Hu Z; Zhang H; Yang M; Xing C; Guo Y
Clin Exp Metastasis; 2024 May; ():. PubMed ID: 38796806
[TBL] [Abstract][Full Text] [Related]
6. PPARĪ± phosphorylation regulates colorectal tumor immune escape.
Gou Q; Tian X; Dong C; Yan B; Chen M; Shi J; Yang L; Hou Y
J Biol Chem; 2024 Jun; ():107447. PubMed ID: 38844134
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the immune symphony: decoding colorectal cancer metastasis through immune interactions.
He R; Huang S; Lu J; Su L; Gao X; Chi H
Front Immunol; 2024; 15():1362709. PubMed ID: 38415252
[TBL] [Abstract][Full Text] [Related]
8. TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer.
Dai X; Wu Z; Ruan R; Chen J; Huang C; Lei W; Yao Y; Li L; Tang X; Xiong J; Feng M; Deng J
Cell Commun Signal; 2024 Mar; 22(1):168. PubMed ID: 38454413
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression.
Zhang H; Xia Y; Wang F; Luo M; Yang K; Liang S; An S; Wu S; Yang C; Chen D; Xu M; Cai M; To KKW; Fu L
Adv Sci (Weinh); 2021 May; 8(10):2003404. PubMed ID: 34026438
[TBL] [Abstract][Full Text] [Related]
10. N
Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
Zhang J; Bu X; Wang H; Zhu Y; Geng Y; Nihira NT; Tan Y; Ci Y; Wu F; Dai X; Guo J; Huang YH; Fan C; Ren S; Sun Y; Freeman GJ; Sicinski P; Wei W
Nature; 2018 Jan; 553(7686):91-95. PubMed ID: 29160310
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
Roshani Asl E; Rasmi Y; Baradaran B
J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
[TBL] [Abstract][Full Text] [Related]
13. BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma.
Yu Z; Wu X; Zhu J; Yan H; Li Y; Zhang H; Zhong Y; Lin M; Ye G; Li X; Jin J; Li K; Wang J; Zhuang H; Lin T; He J; Lu C; Xu Z; Zhang X; Li H; Jin X
Cell Mol Life Sci; 2024 Feb; 81(1):82. PubMed ID: 38340178
[TBL] [Abstract][Full Text] [Related]
14. miR-3133 inhibits gastrointestinal cancer progression through activation of Hippo and p53 signalling pathways via multi-targets.
Zhou L; Guo H; Liao Q; Zou J; Le Y; Fang Z; Xiong J; Huang S; Deng J; Xiang X
J Cell Mol Med; 2023 Oct; 27(20):3090-3106. PubMed ID: 37555915
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
